Top FDA Officials Explain Standards For Take-Home COVID-19 Tests
In an op-ed, two top US COVID-19 regulators say they have a lower threshold for sensitivity for take-home tests to encourage development and increase access to them.
You may also be interested in...
US FDA staff spoke on HHS’s new laboratory developed test edict, as well as ongoing concerns around new test types and reviewer responsiveness in a recent virtual town hall.
After criticism it was being too lax in overseeing COVID-19 antibody tests coming to market, the US agency issued an updated guidance earlier this month tightening regulations. As a result, it has now pulled more than two dozen tests that don’t meet its standards – and more are expected to follow.
The ECRI report of the top threats to the healthcare industry in 2022 has cybersecurity leading the list. COVID-19-related issues such as supply chain shortages and lack of emergency stockpiles are also on the list.